These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34680993)

  • 1. Genes Associated with Disturbed Cerebral Neurogenesis in the Embryonic Brain of Mouse Models of Down Syndrome.
    Ishihara K
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is Neuron-Vascular Communication Disturbed in the Delayed Prenatal Brain Development of a Mouse Model of Down Syndrome?].
    Ishihara K
    Yakugaku Zasshi; 2021; 141(3):369-373. PubMed ID: 33642505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbation of the immune cells and prenatal neurogenesis by the triplication of the Erg gene in mouse models of Down syndrome.
    Ishihara K; Shimizu R; Takata K; Kawashita E; Amano K; Shimohata A; Low D; Nabe T; Sago H; Alexander WS; Ginhoux F; Yamakawa K; Akiba S
    Brain Pathol; 2020 Jan; 30(1):75-91. PubMed ID: 31206867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
    Kurabayashi N; Sanada K
    Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.
    Goodliffe JW; Olmos-Serrano JL; Aziz NM; Pennings JL; Guedj F; Bianchi DW; Haydar TF
    J Neurosci; 2016 Mar; 36(10):2926-44. PubMed ID: 26961948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.
    Liu W; Zhou H; Liu L; Zhao C; Deng Y; Chen L; Wu L; Mandrycky N; McNabb CT; Peng Y; Fuchs PN; Lu J; Sheen V; Qiu M; Mao M; Lu QR
    Neurobiol Dis; 2015 May; 77():106-16. PubMed ID: 25747816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.
    Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K
    Cereb Cortex; 2010 May; 20(5):1131-43. PubMed ID: 19710359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome.
    Najas S; Arranz J; Lochhead PA; Ashford AL; Oxley D; Delabar JM; Cook SJ; Barallobre MJ; Arbonés ML
    EBioMedicine; 2015; 2(2):120-34. PubMed ID: 26137553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comprehensive Analyses of Molecules with Altered Expression in the Brain of a Mouse Model of Down Syndrome for Identification of Pharmacotherapeutic Targets].
    Ishihara K
    Yakugaku Zasshi; 2017; 137(7):807-810. PubMed ID: 28674291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
    Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
    Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the understanding of Down syndrome using mouse models.
    Yamakawa K
    Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic background and application of Down syndrome mouse models.
    Meng XW; Wang J; Ma QW
    Yi Chuan; 2018 Mar; 40(3):207-217. PubMed ID: 29576544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models.
    Mendioroz M; Do C; Jiang X; Liu C; Darbary HK; Lang CF; Lin J; Thomas A; Abu-Amero S; Stanier P; Temkin A; Yale A; Liu MM; Li Y; Salas M; Kerkel K; Capone G; Silverman W; Yu YE; Moore G; Wegiel J; Tycko B
    Genome Biol; 2015 Nov; 16():263. PubMed ID: 26607552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome.
    Contestabile A; Benfenati F; Gasparini L
    Prog Neurobiol; 2010 May; 91(1):1-22. PubMed ID: 20097253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.
    Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ
    Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.
    Nakano-Kobayashi A; Awaya T; Kii I; Sumida Y; Okuno Y; Yoshida S; Sumida T; Inoue H; Hosoya T; Hagiwara M
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10268-10273. PubMed ID: 28874550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype microarrays reveal metabolic dysregulations of neurospheres derived from embryonic Ts1Cje mouse model of Down syndrome.
    Seth EA; Lee HC; Yusof HHBM; Nordin N; Cheah YK; Ho ETW; Ling KH; Cheah PS
    PLoS One; 2020; 15(7):e0236826. PubMed ID: 32730314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.